[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Viral-Vectored Vaccines Sales Market Report 2016

September 2016 | 121 pages | ID: G3B4DF5BDA6EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Viral-Vectored Vaccines

Revenue, means the sales value of Viral-Vectored Vaccines

This report studies sales (consumption) of Viral-Vectored Vaccines in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Bayer HealthCare AG (Germany)
  • Biogenesis-Bago (Argentina)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Sante Animale (France)
  • Heska Corporation (US)
  • Indian Immunologicals Ltd (India)
  • Lohmann Animal Health (US)
  • Merck Animal Health (US)
  • Merial Ltd. (US)
  • Protein Sciences Corporation (US)
  • Virbac SA (France)
  • Zoetis Inc. (US)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Viral-Vectored Vaccines in these regions, from 2011 to 2021 (forecast), like
  • USA
  • China
  • Europe
  • Japan
  • India
  • Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Viral-Vectored Vaccines in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Viral-Vectored Vaccines Sales Market Report 2016

1 VIRAL-VECTORED VACCINES OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Viral-Vectored Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Viral-Vectored Vaccines Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Viral-Vectored Vaccines (2011-2021)
  1.5.1 Global Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Global Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL VIRAL-VECTORED VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Viral-Vectored Vaccines Market Competition by Manufacturers
  2.1.1 Global Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Viral-Vectored Vaccines Revenue and Share by Manufacturers (2011-2016)
2.2 Global Viral-Vectored Vaccines (Volume and Value) by Type
  2.2.1 Global Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Global Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Global Viral-Vectored Vaccines (Volume and Value) by Regions
  2.3.1 Global Viral-Vectored Vaccines Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Viral-Vectored Vaccines Revenue and Market Share by Regions (2011-2016)
2.4 Global Viral-Vectored Vaccines (Volume) by Application

3 USA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 USA Viral-Vectored Vaccines Sales and Value (2011-2016)
  3.1.1 USA Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 USA Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 USA Viral-Vectored Vaccines Sales Price Trend (2011-2016)
3.2 USA Viral-Vectored Vaccines Sales and Market Share by Manufacturers
3.3 USA Viral-Vectored Vaccines Sales and Market Share by Type
3.4 USA Viral-Vectored Vaccines Sales and Market Share by Application

4 CHINA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 China Viral-Vectored Vaccines Sales and Value (2011-2016)
  4.1.1 China Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 China Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  4.1.3 China Viral-Vectored Vaccines Sales Price Trend (2011-2016)
4.2 China Viral-Vectored Vaccines Sales and Market Share by Manufacturers
4.3 China Viral-Vectored Vaccines Sales and Market Share by Type
4.4 China Viral-Vectored Vaccines Sales and Market Share by Application

5 EUROPE VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Viral-Vectored Vaccines Sales and Value (2011-2016)
  5.1.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Viral-Vectored Vaccines Sales Price Trend (2011-2016)
5.2 Europe Viral-Vectored Vaccines Sales and Market Share by Manufacturers
5.3 Europe Viral-Vectored Vaccines Sales and Market Share by Type
5.4 Europe Viral-Vectored Vaccines Sales and Market Share by Application

6 JAPAN VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Viral-Vectored Vaccines Sales and Value (2011-2016)
  6.1.1 Japan Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Japan Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Viral-Vectored Vaccines Sales Price Trend (2011-2016)
6.2 Japan Viral-Vectored Vaccines Sales and Market Share by Manufacturers
6.3 Japan Viral-Vectored Vaccines Sales and Market Share by Type
6.4 Japan Viral-Vectored Vaccines Sales and Market Share by Application

7 INDIA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 India Viral-Vectored Vaccines Sales and Value (2011-2016)
  7.1.1 India Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 India Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  7.1.3 India Viral-Vectored Vaccines Sales Price Trend (2011-2016)
7.2 India Viral-Vectored Vaccines Sales and Market Share by Manufacturers
7.3 India Viral-Vectored Vaccines Sales and Market Share by Type
7.4 India Viral-Vectored Vaccines Sales and Market Share by Application

8 SOUTHEAST ASIA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Viral-Vectored Vaccines Sales and Value (2011-2016)
  8.1.1 Southeast Asia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
8.2 Southeast Asia Viral-Vectored Vaccines Sales and Market Share by Manufacturers
8.3 Southeast Asia Viral-Vectored Vaccines Sales and Market Share by Type
8.4 Southeast Asia Viral-Vectored Vaccines Sales and Market Share by Application

9 GLOBAL VIRAL-VECTORED VACCINES MANUFACTURERS ANALYSIS

9.1 Bayer HealthCare AG (Germany)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Viral-Vectored Vaccines Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Biogenesis-Bago (Argentina)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 121 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Boehringer Ingelheim GmbH (Germany)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 147 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Ceva Sante Animale (France)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Sept Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Heska Corporation (US)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Indian Immunologicals Ltd (India)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Lohmann Animal Health (US)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharmaceuticals Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Merck Animal Health (US)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Merial Ltd. (US)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Protein Sciences Corporation (US)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Virbac SA (France)
9.12 Zoetis Inc. (US)

10 VIRAL-VECTORED VACCINES MAUFACTURING COST ANALYSIS

10.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Viral-Vectored Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL VIRAL-VECTORED VACCINES MARKET FORECAST (2016-2021)

14.1 Global Viral-Vectored Vaccines Sales, Revenue Forecast (2016-2021)
14.2 Global Viral-Vectored Vaccines Sales Forecast by Regions (2016-2021)
14.3 Global Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
14.4 Global Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Global Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Viral-Vectored Vaccines
Figure Global Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure China Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure India Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Figure Global Viral-Vectored Vaccines Sales and Growth Rate (2011-2021)
Figure Global Viral-Vectored Vaccines Revenue and Growth Rate (2011-2021)
Table Global Viral-Vectored Vaccines Sales of Key Manufacturers (2011-2016)
Table Global Viral-Vectored Vaccines Sales Share by Manufacturers (2011-2016)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table Global Viral-Vectored Vaccines Revenue by Manufacturers (2011-2016)
Table Global Viral-Vectored Vaccines Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 Global Viral-Vectored Vaccines Revenue Share by Manufacturers
Table Global Viral-Vectored Vaccines Sales and Market Share by Type (2011-2016)
Table Global Viral-Vectored Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Type (2011-2016)
Table Global Viral-Vectored Vaccines Revenue and Market Share by Type (2011-2016)
Table Global Viral-Vectored Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2011-2016)
Figure Global Viral-Vectored Vaccines Revenue Growth Rate by Type (2011-2016)
Table Global Viral-Vectored Vaccines Sales and Market Share by Regions (2011-2016)
Table Global Viral-Vectored Vaccines Sales Share by Regions (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Regions (2011-2016)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Regions (2011-2016)
Table Global Viral-Vectored Vaccines Revenue and Market Share by Regions (2011-2016)
Table Global Viral-Vectored Vaccines Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Viral-Vectored Vaccines by Regions (2011-2016)
Figure Global Viral-Vectored Vaccines Revenue Growth Rate by Regions (2011-2016)
Table Global Viral-Vectored Vaccines Sales and Market Share by Application (2011-2016)
Table Global Viral-Vectored Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Viral-Vectored Vaccines by Application (2011-2016)
Figure Global Viral-Vectored Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure USA Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure USA Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table USA Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table USA Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table USA Viral-Vectored Vaccines Sales by Type (2011-2016)
Table USA Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table USA Viral-Vectored Vaccines Sales by Application (2011-2016)
Table USA Viral-Vectored Vaccines Market Share by Application (2011-2016)
Figure China Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure China Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure China Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table China Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table China Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table China Viral-Vectored Vaccines Sales by Type (2011-2016)
Table China Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table China Viral-Vectored Vaccines Sales by Application (2011-2016)
Table China Viral-Vectored Vaccines Market Share by Application (2011-2016)
Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Europe Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Europe Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table Europe Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table Europe Viral-Vectored Vaccines Sales by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table Europe Viral-Vectored Vaccines Sales by Application (2011-2016)
Table Europe Viral-Vectored Vaccines Market Share by Application (2011-2016)
Figure Japan Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Japan Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Japan Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Japan Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table Japan Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table Japan Viral-Vectored Vaccines Sales by Type (2011-2016)
Table Japan Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table Japan Viral-Vectored Vaccines Sales by Application (2011-2016)
Table Japan Viral-Vectored Vaccines Market Share by Application (2011-2016)
Figure India Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure India Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure India Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table India Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table India Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table India Viral-Vectored Vaccines Sales by Type (2011-2016)
Table India Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table India Viral-Vectored Vaccines Sales by Application (2011-2016)
Table India Viral-Vectored Vaccines Market Share by Application (2011-2016)
Figure Southeast Asia Viral-Vectored Vaccines Sales and Growth Rate (2011-2016)
Figure Southeast Asia Viral-Vectored Vaccines Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Viral-Vectored Vaccines Sales Price Trend (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Sales by Manufacturers (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Market Share by Manufacturers (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Sales by Type (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Market Share by Type (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Sales by Application (2011-2016)
Table Southeast Asia Viral-Vectored Vaccines Market Share by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ceva Sante Animale (France) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Heska Corporation (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lohmann Animal Health (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Animal Health (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merial Ltd. (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Protein Sciences Corporation (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Virbac SA (France) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zoetis Inc. (US) Viral-Vectored Vaccines Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure Global Viral-Vectored Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Global Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Regions (2016-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Type (2016-2021)
Table Global Viral-Vectored Vaccines Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories